Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial

BACKGROUND: For HIV-1-infected young people facing lifelong antiretroviral therapy (ART), short cycle therapy with long-acting drugs offers potential for drug-free weekends, less toxicity, and better quality-of-life. We aimed to compare short cycle therapy (5 days on, 2 days off ART) versus continuo...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995440/
https://www.ncbi.nlm.nih.gov/pubmed/27562743
http://dx.doi.org/10.1016/S2352-3018(16)30054-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995440/
https://www.ncbi.nlm.nih.gov/pubmed/27562743
http://dx.doi.org/10.1016/S2352-3018(16)30054-6

Ejemplares similares